• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

China

pills-drugs-pharma
China's Avistone Pharmaceuticals raises $200m

Avistone Pharmaceuticals, a Beijing biotech company focused on precision oncology therapeutics has raised more than $200 million in a Series A funding round led by Vivo Capital.

  • Greater China
  • 14 December 2021
Biotech player CANbridge drops on debut after $87m HK IPO

CANbridge Pharmaceuticals, a Beijing-based drug developer that focuses on treatments for cancer and rare diseases, lost 27% in value on its Hong Kong trading debut following a HK$685.1 million ($87.8 million) IPO.

  • Greater China
  • 13 December 2021
imab-biotech-drug-healthcare
China’s ABclonal Technology raises $189m

Chinese life science research and diagnostic reagents provider ABclonal Technology has raised a RMB1.2 billion ($189 million) Series D round featuring Sequoia Capital China.

  • Greater China
  • 10 December 2021
L Catterton backs China-based Amazon vendor aggregator

Nebula Brands, a China-based aggregator of Amazon vendors, has raised $50 million in Series B funding led by L Catterton Asia.

  • Greater China
  • 09 December 2021
HarbourVest hires Allianz executive for China institutional busines

HarbourVest Partners has recruited Cicely Sun from Allianz Global Investors as a managing director and co-head of its Beijing office.

  • Greater China
  • 09 December 2021
artificial-intelligence-ai
China's SenseTime plans pared back Hong Kong IPO

Chinese artificial intelligence (AI) technology developer SenseTime is looking to raise up to HK$5.99 billion in a Hong Kong IPO that is considerably smaller than originally envisaged.

  • Greater China
  • 08 December 2021
james-mi-lightspeed
Fund focus: Lightspeed bets on green-tech

Green-tech is the latest big idea being championed by Lightspeed China Partners. It has inspired a change in the firm’s name and it will underpin deployment of the new $920 million fund

  • Greater China
  • 08 December 2021
gaussian
Deal focus: Gaussian serves China’s aged

With its globally competitive technology and low costs, Gaussian Robotics has become a dominant force in the cleaning robot segment. SoftBank Vision Fund is the latest addition to its cap table

  • Greater China
  • 08 December 2021
money-dollar-spender-businessman
Asia exits: Pass the parcel

Sponsor-to-sponsor exits are set to reach a record high in Asia this year as private equity firms increase velocity of deployment and some strategics remain in a pandemic-induced funk

  • GPs
  • 08 December 2021
hospital-operation-surgery-healthcare
China surgical robotics player RainMed raises $100m

Ping An Capital has led a Series D round of approximately $100 million for RainMed Medical, a China-based surgical robotics business. Other investors include Seresia Asset Management and Lighthouse Canton.

  • Greater China
  • 07 December 2021
chris-sun-kkr
KKR promotes Chris Sun to partner

Chris Sun (pictured), a managing director at KKR who focuses on investments in China’s consumer sector, has been promoted to partner.

  • Greater China
  • 06 December 2021
China 3D printing start-up WeNext raises $55m

Temasek Holdings, Cathay Capital Private Equity, and Haochen Capital have led a $55 million Series B round for WeNext Technology, a China-based 3D printing specialist.

  • Greater China
  • 06 December 2021
China's Didi to delist in New York

China ride-hailing platform Didi, which has traded poorly ever since being targeted by regulators in the wake of its IPO in June, plans to delist from the New York Stock Exchange and relist in Hong Kong.

  • Greater China
  • 04 December 2021
semiconductor-chip-03
Wise Road buys semiconductor assets from Taiwan's ASE

Wise Road Capital, a China-based private equity firm that focuses on high-tech investments, has agreed to buy a package of assets from Taiwan-listed semiconductor business ASE Technology Holding for $1.46 billion.

  • Greater China
  • 03 December 2021
avcj-20211130cvr-72
Weekly digest - December 01 2021

  • Region
  • 01 December 2021
ev-electric-vehicle-charging
China cleantech: Policy tailwinds

Private equity investment in China cleantech and renewables is at record levels, spurred by robust government support for the industry and a recognition that this time the boom might be sustainable

  • Greater China
  • 01 December 2021
Lightspeed China closes US dollar fund at $920m

Lightspeed China Partners has closed its latest US dollar-denominated fund at $920 million. It is the largest fund raised by the firm and brings assets under management to $3 billion.

  • Greater China
  • 01 December 2021
saas-software-enterprise
China procurement services start-up raises $102m

Chinese procurement management platform Going-Link, also known as Zhenyun, has raised a RMB650 million ($102 million) Series C round led by Meituan-backed DragonBall Capital.

  • Greater China
  • 01 December 2021
coronavirus-covid-vaccine-healthcare
Vision Fund joins $300m round for China vaccine developer

SoftBank Vision Fund 2 and 5Y Capital have led a $300 million Series C extension for Suzhou Abogen Biosciences, a Chinese vaccine developer focused on mRNA products, including one for COVID-19.

  • Greater China
  • 01 December 2021
DCP leads $235m round for China's Datong Insurance

DCP Capital Partners has become the largest institutional shareholder in Datong Insurance Service, one of China’s leading insurance brokerages, after leading a RMB1.5 billion ($235 million) round.

  • Greater China
  • 30 November 2021
Legend hits first close on healthcare fund, launches TMT vehicle

Legend Capital has reached a first close of $177 million on its third US dollar-denominated China healthcare fund. It is one of five vehicles the GP has in the market, including its recently launched ninth flagship technology, media, and telecom (TMT)...

  • Greater China
  • 29 November 2021
pills-drugs-pharma
Qiming leads $40m round for Allorion Therapeutics

China and US-based precision medicine company Allorion Therapeutics has raised a $40 million Series A round led by Qiming Venture Partners.

  • Greater China
  • 29 November 2021
avcj-hong-kong-2021-secondaries
Secondaries supply-demand mismatch most extreme in Asia - AVCJ Forum

There is not enough capital in Asia to address the number of secondary opportunities – mirroring the situation globally – with investors claiming to have more transaction choices than ever before.

  • Greater China
  • 26 November 2021
chip-semiconductor-circuit-lab
China GPU chip designer secures $313m Series A

Moore Threads, a Chinese chip designer established 13 months ago by a team from Nvidia, has closed Series A at RMB2 billion ($313 million) led by Shanghai Guosheng Capital, 5Y Capital, and a BOC International fund.

  • Greater China
  • 26 November 2021
32 33 34
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013